Objectives: Repetitive transcranial magnetic stimulation (rTMS) is a potential therapeutic intervention for the treatment of addiction. This critical review aims to summarise the recent developments with respect to the efficacy of rTMS for all types of addiction and related disorders (including eating disorders), and concentrates on the associated methodological and technical issues. Methods: The bibliographic search consisted of a computerised screening of the Medline and ScienceDirect databases up to December 2013. Criteria for inclusion were the target problem was an addiction, a related disorder, or craving; the intervention was performed using rTMS; and the study was a clinical trial. Results: Of the potential 638 articles, 18 met the criteria for inclusion. Most of these (11 of the 18) supported the efficacy of rTMS, especially in the short term. In most cases, the main assessment criterion was the measurement of craving using a Visual Analogue Scale. Discussion: The results are discussed with respect to the study limitations and, in particular, the many methodological and technical discrepancies that were identified. Key recommendations are provided.
Introduction
Addictions are complex illnesses, and are the subject of many research studies. A recent review paper suggested that over half the adult population of the United States reported symptoms reminiscent of current addictive disorders (Sussman et al., 2011) . Addictions can be defined as "a condition in which a behaviour that can function both to produce pleasure and to reduce painful affects is employed in a pattern that is characterised by two key features: (1) recurrent failure to control the behaviour, and (2) continuation of the behaviour despite significant harmful consequences" (Goodman, 1990 (Goodman, , 2008 . Despite this minimalist but generally agreed upon behavioural definition, different addictions display many similarities in terms of risk factors, the frequency of comorbidities and the trajectory, which is marked by periods of relative control or abstinence alternating with periods of relapse (Goodman, 2008) . Finally, different types of addiction share a number of clinical symptoms such as drug-seeking behaviour, feelings or thoughts directed towards pathological behaviour pervading the mind and impulsive action followed by periods of struggle with anxiety of varying length (Le Moal and Koob, 2007; Dickson et al., 2011) . Compulsivity and impulsivity are the two main factors involved in a composite addiction cycle, which can be characterised by three successive stages: binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation, also known as the "craving stage" (Koob and Volkow, 2010) .
Addictions are not only limited to substance use disorders (SUD). Indeed, it is now widely agreed that they also relate to non-drug behaviours (e.g. gambling or shopping) and substances that have not traditionally been viewed as addictive (e.g. food) (Gearhardt et al., 2011) . Whether they are linked to SUD or behavioural addictions, also known as "related disorders" (RD), they actually have a great deal in common despite their apparent clinical heterogeneity and mainstream thinking increasingly views SUD and RD as a coherent whole. This is highlighted in the latest version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), where a new category entitled "Addiction and RD" combines SUD and gambling disorders and drops the former categories of abuse and dependence (O'Brien, 2011) . Although not included in the DSM-5, several other disorders were considered relating to the Internet, sex, exercise and shopping (Potenza, 2014a) . It is expected that this list is non-exhaustive. Addiction relating to food was not considered by the research workgroup, due to existing debates on the topic (Potenza, 2014a) , and grouping eating disorders under the label "addictions" remains controversial. Despite this, more and more authors support this idea (Speranza et al., 2012; Potenza, 2014b) . The umbrella term of eating disorders encompasses a broad spectrum, with anorexia nervosa (AN) at one end and binge eating disorder (BED) at the other, and also includes bulimia nervosa (BN) and other specified feeding and eating disorder (OSFED). BN, BED and, to a lesser extent, OSFED share behavioural and clinical characteristics with other types of addictive disorders (Volkow and O'Brien, 2007; Kinzl and Biebl, 2010; Gearhardt et al., 2011; Speranza et al., 2012; Davis, 2013; Curtis and Davis, 2014) . In particular, they meet the diagnostic criteria proposed by Goodman (Goodman, 2008; Speranza et al., 2012) . They also share neurobiological processes with other addictive disorders (Cota et al., 2006; Cowin et al., 2011; Gearhardt et al., 2011; Avena and Bocarsly, 2012; Umberg et al., 2012; Kaye et al., 2013; Volkow et al., 2013) . Conceptualising AN as a behavioural addiction is perhaps somewhat more complicated. Indeed, people with AN are not addicted to food but quite the opposite, they are addicted to food deprivation, and they show real determination instead of losing control. Because of these opposing behavioural features, AN and BN could be regarded as two sides of the same coin. In particular, they are characterised by a persistent preoccupation with food and dysfunctional cognition related to body weight and body image (Avena and Bocarsly, 2012) , and by the same brain alterations, for example, increased grey matter volume of the medial orbitofrontal cortex and reduced white matter in the right temporal and parietal areas relative to healthy individuals (Frank et al., 2013) . The neural molecular events driving self-restriction are detected in the nucleus accumbens, strengthening the idea of the addictive facet of restrictive diet underpinned by a rewarding effect associated with energy expenditure (Jean et al., 2012) . For all of these reasons, AN could also be considered as a behavioural addiction or a RD, especially of the binge-eating/purging type.
Craving is one of the most striking symptoms of addiction and RD, as emphasised by the composite addiction cycle previously mentioned (Koob and Volkow, 2010) . It has been the subject of growing attention, to the extent that it is listed as one of the diagnostic criteria in the category "Addiction and RD" (O'Brien, 2011) . Craving is defined as a pressing, urgent and irrepressible desire to give in to an addictive behaviour, and results in the loss of control in most cases (Skinner and Aubin, 2010) . In addition to the extensive literature in the field of drug craving, there is also a wide range of information about food craving (Bou Khalil and El Hachem, 2013; Jansen et al., 2013) . Beyond the mere desire to take a drug or food or to gamble, for example, craving also includes the expectation of positive effects and the relief of negative effects as a result of this action (Young and Wohl, 2009) . It is a persistent symptom that can arise spontaneously or be cue-induced by exposing the subject to various stimuli related to the addictive behaviour through classical conditioning (Watson, 1913) . Incidentally, animal models of craving are based on two behaviours: drugseeking induced by drugs or stimuli previously associated with drug-taking, and drug-seeking induced by an acute stressor or a residual negative emotional state (Koob and Volkow, 2010) . It is possible to generalise this phenomenon to food craving (Avena and Bocarsly, 2012; Marco et al., 2012) . Despite long periods of abstinence, craving can reappear and increase the likelihood of relapse (Koob and Volkow, 2010; Skinner and Aubin, 2010; Marhe et al., 2013) . Special attention must therefore be paid to managing cravings during the treatment of an addicted subject. Craving can also be cue-induced in an experimental setting to gain a better understanding of the role it plays in the decision-making process and to determine its neuro-cognitive correlates, as well as to test the efficacy of medication in reducing craving scores (Franklin et al., 2011; Potenza et al., 2012; Goldman et al., 2013; McGrath et al., 2013; Veilleux et al., 2013) . Studies have shown that cravings are underpinned by activation of the reward and motivation circuits (McBride et al., 2006; Wang et al., 2007; Wing et al., 2012; Goldman et al., 2013; Jansen et al., 2013; Volkow et al., 2013) . According to these authors, the main neural structures involved are: the nucleus accumbens, dorsal striatum, orbitofrontal cortex, anterior cingulate cortex, dorsolateral prefrontal cortex (DLPFC), amygdala, hippocampus and insula. While the left DLPFC, as determined by fMRI, appears to play a crucial role in increasing self-control over cravings (Hayashi et al., 2013) , the right DLPFC may be involved in the inhibitory control of affective impulses (Pripfl et al., 2013a) . However, a lack of empirical evidence for hemispheric differences in DLPFC in addiction excludes definitive conclusions.
Aside from the many features these disorders share, as mentioned above, there are also similarities in the therapeutic approaches (Goodman, 2008) . These are most often based on psychotherapy, which is administered using a range of different methods (Goodman, 1990; Potenza et al., 2011) . For more than 30 years, researchers have been developing methods for adjuvant care, particularly in the field of pharmacotherapy . Many different molecules have been tested. Unfortunately, the results of such trials have not been completely successful in meeting expectations (Achab and Khazaal, 2011; Muller et al., 2011; Bolt et al., 2012; Mariani and Levin, 2012) . More recently, new treatment modalities such as brain stimulation have been explored.
Transcranial magnetic stimulation (TMS) is a medical tool that first appeared over 20 years ago (Barker, 1999) . This neuromodulation technique is based on the principle of electromagnetic induction and consists of magnetic pulses to induce electrical currents in the brain via a coil placed on the scalp. This leads to cerebral neuromodulation through the modification of cortical excitability (Daskalakis et al., 2006) , of blood flow to the area (Bestmann et al., 2005) , of the frequency of neuronal discharge (Barr et al., 2009) , and of the release of neurotransmitters such as dopamine (Strafella et al., 2003; Cho and Strafella, 2009 ). In addition to its cortical action, TMS is said to act remotely on deeper structures, via brain circuits and interhemispheric connections (Fox et al., 1997) . Initially, TMS was used to study motor conductivity; however, the effect of stimulation was extremely short-lived and disappeared almost instantaneously. Later, the ability to deliver multiple pulses via repetitive TMS (rTMS) enabled longer lasting effects and investigations into cognition, brain-behaviour relations and the pathophysiology of various neurologic and psychiatric disorders (Wassermann and Lisanby, 2001; Kobayashi and PascualLeone, 2003; Tassinari et al., 2003; Rossi and Rossini, 2004; Ridding and Rothwell, 2007) . High frequency (HF) stimulation (>5 Hz) is considered to have excitatory effects on the cortical activity whereas low frequency (LF) stimulation (<1 Hz) is considered to have inhibitory effects (Pascual-Leone et al., 1994) . Animal and human studies have concluded that rTMS may have a therapeutic effect by altering cortical excitability through the modulation of neurotransmitters including dopamine and GABA (Barr et al., 2011) . Successive studies have broadened the range of therapeutic applications in the field of neurological, re-educational and psychiatric pathologies. One line of research to emerge recently examines the efficacy of rTMS on addiction and RD by targeting craving in particular.
Experimental studies suggest that there is indeed a dopaminergic dysfunction of the mesolimbic systems in addicts (Goodman, 2008) . According to some authors, symptoms of addiction and RD could be alleviated by "boosting" dopaminergic transmission (Diana, 2011) , which may be achieved via TMS.
Because of their deep brain localisation, dopaminergic neurons are indirectly stimulated during rTMS, through their more superficial projections, especially in the DLPFC (Diana, 2011) . The DLPFC is involved in cognitive control and the physiopathology of impulse control disorders, such as addiction and RD (Crockford et al., 2005; Wang et al., 2007; Van Holst et al., 2010) . rTMS applied to the DLPFC may therefore indirectly modulate dopaminergic pathways (Addolorato et al., 2012) and may consequently have an impact on the symptoms of addiction (Keck et al., 2002; Feil and Zangen, 2010) : cognitive control could be improved and/or cravings could be reduced (Jansen et al., 2013) .
The first articles to assess the value of rTMS to treat addictive disorders date back to 2003 Johann et al., 2003) . Uncovering a role for rTMS treatment for addiction and RD has been approached from a number of different perspectives and in many different ways (original research, reviews, and comprehensive work), namely by focusing on case studies (Hausmann et al., 2004; De Ridder et al., 2011; Downar et al., 2012; McClelland et al., 2013b; Baczynski et al., 2014) ; one substance at a time (Hoppner et al., 2011; Nardone et al., 2012; Wing et al., 2013) ; including all SUDs (Barr et al., 2008; Feil and Zangen, 2010; Barr et al., 2011; Addolorato et al., 2012; Bellamoli et al., 2014) ; eating disorders (Van den Eynde and Guillaume, 2012; McClelland et al., 2013a) ; one symptom of addiction at a time, such as craving (Jansen et al., 2013) ; dependence, or cognitive impairment (Knoch et al., 2006) ; comprehensive physiopathological approaches (Keck et al., 2002; Strafella et al., 2003; Barr et al., 2008; Camus et al., 2009; Cho and Strafella, 2009; Diana, 2011; Hayashi et al., 2013) ; one neuromodulation technique at a time (Barr et al., 2008 (Barr et al., , 2011 Hoppner et al., 2011; Addolorato et al., 2012; Bellamoli et al., 2013; Rosenberg et al., 2013) or several techniques investigated simultaneously (Feil and Zangen, 2010; Van den Eynde and Guillaume, 2012; Jansen et al., 2013; Wing et al., 2013) . Several "magnetic techniques" have also been tested in addiction and RD such as transcranial dynamic magnetotherapy (TcDMT) in the complex treatment of alcohol withdrawal syndrome (Staroverov et al., 2009 ) and deep TMS in pathological gambling (Rosenberg et al., 2013) . Although these techniques use magnetic fields, they are not completely comparable to rTMS. Their mechanistic properties, working on the principle of electromagnetic induction are similar. However, they differ regarding their depth of penetration and the focality of the magnetic field, mainly because they use different coils. rTMS most often uses a figure-8 coil, which induces an electric field restricted to superficial cortical targets, up to 3 cm (Rossi et al., 2009) due to its rapid attenuation in depth. Deep TMS is designed to reach greater depths than rTMS, reaching up to 6 cm (Bersani et al., 2013) via an H-coil. Figure-8 coils produce a more focal and shallower stimulation compared to H-coils.
First and foremost, we support the idea that all types of addiction can be compared using a comprehensive approach that Number of studies identified through searches = 638
Included studies = 18
Screening inclusion criteria -The target problem w as a SUD or related disorder -The intervention consisted of rTMS -The study was a clinical trial
Screening exclusion criteria
-Animal models -Studies into risk-taking behaviour or decision-making -Lack of methodological data -Addictions with mood and psychotic comorbidities in particular -Studies with only a physiopathological aim -Case reports -Reviews
Unduplicated research = 484 considers physiopathological, clinical and therapeutic aspects. In this paper, we consider both addiction and RD. We also support the idea that behavioural changes ought to be considered, not just craving. Finally, we think that a systematic comparison of all non-invasive neuromodulation techniques (e.g., transcranial Direct Current Stimulation and rTMS) is not plausible because these techniques do not share the same procedures and because research in this field is too recent and heterogeneous to currently perform specific meta-analyses. The purpose of this article is to critically review the progress in the use of rTMS since its inception to treat addiction and RD, and in particular the developments in its therapeutic efficacy. This is particularly important as it will allow us to identify the most successful approaches, summarise the progress made, and highlight the lessons to be learned from the difficulties encountered. This review will first discuss the methodological issues, followed by the technical issues of rTMS applied to addiction and RD. Finally, future directions and key recommendations will be proposed. To our knowledge, this work is the first to provide a summary that covers all types of addiction, including SUD and RD in the field of rTMS and to offer a critical assessment of the methodological and technical issues raised.
Methods

Search strategy
We identified articles for inclusion in this review by searching the MEDLINE and ScienceDirect databases up to December 2013, limiting the search to articles published in English and German (one article). The key words used were "TMS" or "rTMS" AND one of the following terms: "addiction", "alcohol", "amphetamine", "methamphetamine", "anorexia nervosa", "behavioural addiction", "benzodiazepine", "binge eating disorder", "bulimia nervosa", "cannabis", "cocaine", "compulsive buying/shopping", "craving", "DLPFC", "dopamine", "drug", "eating disorder", "ecstasy", "EDNOS" 1 , "exercise", "food craving", "impulsivity", "LSD", "nicotine", "opiate", "pathological gambling", "sex addiction", "smoking", "sport addiction", and "tobacco". A manual search and a screening of the bibliography of the selected studies were performed in addition to the computerised screening. Duplicate searches were eliminated. The search strategy is summarised in Figure 1. 
Eligibility criteria
Studies had to fulfil the following criteria to be included: -The target problem was an addiction, a RD or craving -The intervention was performed using rTMS -The study was a clinical trial (e.g., any research study concerning human beings, including pilot studies and randomised clinical trials) (WHO, 2014).
Study selection
First, all studies were screened based on their titles and abstracts. Second, the two authors read the full text of all studies identified in this search process. They carried out this work independently using the same bibliographic search. In the event of a disagreement between them, the relevant studies were discussed.
Data extraction
The data extraction work was divided between the two authors. Extracted data included clinical, general, and technical considerations.
Results
Eighteen articles met the criteria for inclusion. The disorders tested were nicotine, alcohol, cocaine and methamphetamine dependence, and eating disorders (food craving, AN, BN and EDNOS). Of the 18 studies included, only one was a non-controlled study (Politi et al., 2008) . To the best of our knowledge, we assume that rTMS has not yet been tested in the following addictive disorders: ecstasy, LSD or opiate use disorders, compulsive buying/shopping, pathological gambling, sex addiction and exercise addiction.
Efficacy of rTMS
The results are summarised in Table 1 .
rTMS and nicotine
The first studies to test the efficacy of rTMS in the sphere of addictions were carried out in nicotine-dependent subjects Johann et al., 2003) . Both studies adopted a crossover design. In one of the studies, two sessions were carried out, compared to four sessions in the other study. Compared to the placebo, real stimulation produced a significant reduction in cravings and in cigarette consumption during the hours that followed rTMS . Later, Amiaz and colleagues used a design with parallel groups of 10 daily sessions followed by a maintenance period (Amiaz et al., 2009 ). The authors observed significant reductions in cigarette consumption (assessed by urine cotinine levels) and nicotine dependence (assessed by the Fagerström test). Exposure to smoking-related cues followed by active rTMS produced a specific positive effect after 10 sessions by reducing the craving for nicotine, which tended to disappear after 6 months. Another trial offered additional information to improve our understanding of the influence of the superior frontal gyrus on nicotine craving rather than being a real test of the efficacy of rTMS (Rose et al., 2011) . These studies are described in the literature review by Wing et al. (2013) . This review also reports preliminary work with the aim of studying the efficacy of rTMS combined with nicotine replacement in subjects with strong nicotine dependence but also suffering from schizophrenia (Wing et al., 2012) . This study was not included in our analysis because of this specific comorbidity. Finally, the last study successfully demonstrated that a single session of HF rTMS over the DLPFC could significantly reduce cigarette craving induced by cue exposure (Li et al., 2013a) .
rTMS and alcohol
Despite the strong prevalence of alcohol use disorders and the absence of effective treatment for some patients, rTMS has only been tested on alcohol-dependent patients very recently. We have listed three studies that included alcohol-dependent subjects who had just completed detoxification. Two of the studies used 10 daily sessions of rTMS, applied to the right (Mishra et al., 2010) or left (Hoppner et al., 2011) DLPFC. The third study adopted a crossover design with two rTMS sessions, one active and one placebo, applied to the right DLPFC (Herremans et al., 2012) . The study by Mishra and colleagues was carried out as a single blind trial and indicated that real stimulation was superior, with a reduction in craving lasting for four weeks after the completion of the active rTMS sessions (Mishra et al., 2010) . Conversely, the next two studies reported negative results as they failed to show a significant reduction in craving after active rTMS (Hoppner et al., 2011; Herremans et al., 2012) .
rTMS and cocaine
As far as we are aware, only two studies have been published with the aim of evaluating the efficacy of rTMS on craving among cocaine-dependent subjects. All of the patients studied had previously completed their cocaine detoxification. In both studies, the authors concluded that rTMS had a positive effect. Nevertheless, there were a number of important differences between these studies. The aim of the first study was to compare the effects of rTMS according to the side of the brain it was applied to (Camprodon et al., 2007) . The results showed that rTMS had only a transient effect. In contrast, the other study was not controlled but was of interest because it showed that 10 daily sessions of rTMS delivered to the left DLPFC produced a significant reduction in craving over time (Politi et al., 2008) . Despite these promising results, no further studies have been reported.
rTMS and methamphetamine
In a single-blind, sham-controlled crossover study, Li and colleagues recently suggested that LF rTMS on the left DLPFC transiently increased cue-induced craving in methamphetamine participants (Li et al., 2013b) .
rTMS and food
The body of literature in the field of eating disorders, and more broadly that of food craving, provides the most evidence of rTMS treatment efficacy. Seven studies have been published to date. Five of these were carried out by the same team (Uher et al., 2005; Van den Eynde et al., 2010a , 2010b , 2013 Claudino et al., 2011) , which probably explains their similarities, and two of them were based on patients included in a previous study (Van den Eynde et al., 2010b) . All of these studies except one (Van den Eynde et al., 2010b) included only women who had a history of BN or EDNOS-bulimic type (Walpoth et al., 2008; Van den Eynde et al., 2010a , 2010b Claudino et al., 2011) . For the most part, the studies were randomised, double-blind, sham-controlled, parallel group trials. All except one (Walpoth et al., 2008) aimed to investigate the efficacy of a single rTMS session delivered to the left DLPFC on induced food craving. In most of the studies the assessment criteria were score variations on Visual Analogue Scales. One study used a more objective physiological measurement of craving, by repeating salivary cortisol assays (Claudino et al., 2011) , while another chose to use an indirect reflection of craving based on the change in frequency of binges and purges (Walpoth et al., 2008) . As shown in summary Table 1, four of the seven studies listed concluded that rTMS is effective.
rTMS technical procedures
The results are summarised in Table 2 .
The rTMS device
The equipment most frequently used was MagStim (12 studies), far ahead of Neuronetics (three studies). Only three studies failed to specify the equipment used. Most of the studies in which the equipment was specified used focal coils, such as the 8-figured coil.
Stimulation site and identification of the target site
The cortical target most often selected was the left DLPFC (14 studies) with the right DLPFC being chosen much less frequently (two studies). Just one study compared the efficacy of both target regions (Camprodon et al., 2007) . Another chose to compare SFG and MOC (Rose et al., 2011) . The DLPFC was most often located using the "5 cm" or "6 cm" empirical method (10 studies), by moving the coil 5 or 6 cm anterior to the motor cortex, along a parasagittal line (Herbsman et al., 2009; George and Post, 2011) . Two studies used the international EEG system or "10-20 method" (Hoppner et al., 2011; Rose et al., 2011) . Only one study used neuronavigation with 3D-MRI (Herremans et al., 2012) . Only four studies failed to Investigate the effect of rTMS on alcohol craving.
Measure of craving (OCDS).
Negative
No significant between-group difference. Handedness. Psychotropic treatments (in particular, continuation of anti-craving drugs during the trial). Duration of the session, which may overlap with the duration required for the craving to subside naturally. Cumulative and persistent effects of rTMS when the interval between two sessions is very short. Sample size. Ability of the treatment-seeking participants to use relapse prevention techniques during cue-induced craving procedure.
NB: All these biases are discussed in Section 4.
state that identification method that was used Camprodon et al., 2007; Politi et al., 2008; Walpoth et al., 2008) .
General design of the sessions and rTMS parameters
The number of sessions also varied from one study to the next. Most of them (12) studied the effect of rTMS in a single active session compared with a placebo. One third of the studies examined the effect of rTMS over several sessions, often around a dozen sessions. HF was used in most cases, with 10 Hz being the most common (10 studies). Only two studies tested LF (Rose et al., 2011; Li et al., 2013b) . The motor threshold (MT), which in turn determines the intensity of the rTMS was, in most cases (10 of 18), determined using the visual method (i.e., by watching mobilisation of the long thumb abductor), a less accurate method than using an electromyogram (EMG), which was used in two studies (Mishra et al., 2010; Herremans et al., 2012) . Six studies did not list details for this parameter. The intensity used, as a percentage of resting MT, ranged from 90% (5 studies) to 120% (1 study). The majority of studies used intensities between 100% (5 studies) and 110% (7 studies). A considerable majority of the studies (12) divided stimulation into 20 trains. The inter-train interval, which is also a safety parameter, was greater than 20 s (a maximum of 60 s) in 12 studies. The total number of pulsations, which is an essential parameter for rTMS efficacy (Gershon et al., 2003) , was most often set at 1000 or above per session (13 studies). The duration of the session (15-20 min) was stipulated in half of the studies.
Sham procedures
The placebo method is most often described and in most cases is based on the use of a sham coil (7 studies). Four studies used Transcutaneous Electrical Nerve Stimulation (TENS) as well, which increases the effectiveness of the placebo (Walpoth et al., 2008; Barth et al., 2011; Li et al., 2013a Li et al., , 2013b . Four studies used an active coil, reducing its activity either by inclination at an angle of 45 • -90 • , or by applying a metallic plate to the surface to limit the spread of the magnetic signal. Only four studies noted the efficacy of blinding (Van den Eynde et al., 2010b Eynde et al., , 2013 Barth et al., 2011; Claudino et al., 2011) .
Safety and tolerance
Finally, eight studies did not specify rTMS tolerance, which was generally good, as shown in four studies in which no side effects were reported. Only one study reported a case of serious side effects (seizure, probably due to discontinuing benzodiazepine too soon) (Mishra et al., 2010) .
Discussion
Most studies supported rTMS efficacy, especially in the short term, regardless of the comparison with a sham stimulation. A very recent meta-analysis argued that non-invasive neurostimulation of the DLPFC decreases craving levels in substance dependence (Jansen et al., 2013) . However, its efficacy deserves to be discussed in light of many methodological and technical disparities. All sources of bias, shown in Table 3 , will be discussed.
Methodological issues
Sample size and scope of application
The scope of application of rTMS is vast and all of the studies were limited by small sample sizes. The study completed by Amiaz and colleagues had the highest number of subjects (N = 52), but the sample was divided into four groups (Amiaz et al., 2009 ). To compensate for this disadvantage, many studies were carried out with a crossover design to generate greater power. Some articles do not state the duration or severity of the disorder (Camprodon et al., 2007; Politi et al., 2008; Herremans et al., 2012) , whereas these same variables could not be taken into consideration statistically in the other studies due to their small sample sizes. In particular, a study of the link between the measurement of craving and these dimensional variables, or subgroup analyses (i.e., rTMS efficacy in "short" versus "long duration of the illness" subgroups), was not performed. Only the study by Li et al. (2013a) found a positive correlation between reduced craving and the severity of nicotine dependence. Age, gender, the neurotoxic effects of psychoactive substances (in particular alcohol) and the neurocognitive effect of being underweight are all factors that can influence the severity of the disorder. Some patients had completed detoxification prior to start of the studies (for example , when others had been exposed to cues with the specific aim of increasing their craving (for example: Uher et al., 2005) .
Characteristics of the participants
The populations studied were heterogeneous, and this heterogeneity may explain the differences in results. Some participants had a characterised disorder (for example : Mishra et al., 2010) , while others only had a symptom (food craving in healthy people, for example: Uher et al., 2005) . Some of them were previously detoxified (for example: Herremans et al., 2012) , while others continued to use a substance (for example: Amiaz et al., 2009 ). Some of them were undergoing treatment (for example : Hoppner et al., 2011) , while others were recruited through advertisements (for example . In this particular case, the participants wished to quit smoking, but their demand for care was not entirely spontaneous. They were only enrolled in an experimental protocol using rTMS, and not in a traditional smoking cessation programme. The main selection bias was primarily linked to the way the subjects were recruited. Indeed, noting the treatment status of the participants is a crucial issue, and some authors argued that non-treatment seeking addicted participants showed more cue-induced craving than those who were seeking treatment, resulting in an overestimation of intensity (Wertz and Sayette, 2001; Wilson et al., 2004) . When the participants were seeking or undergoing treatment, it may be assumed that their disorders were more severe and long-standing, alleviating the effect of rTMS. On the other hand, it may be argued that participants undergoing treatment had learned to self-control their cravings. This was all the more true when they had received prior psychotherapy. In this context, participants could use relapse prevention techniques, such as thought-stoppage or urge surfing, leading to an underestimation of craving intensity (Wanigaratne et al., 1990) . This may interfere with the interpretation of the results, concluding that rTMS is effective. To our knowledge, participants were not asked to avoid using relapse prevention techniques during cue-induced craving tasks. 4.1.2.1. Age. Elderly subjects and a smaller volume of frontal grey matter are associated with a poorer response to rTMS (Jorge et al., 2008) for patients with vascular depression. Although patients included in the studies we reviewed were rather young (under 60 years old), some of their addictive disorders are known to reduce grey matter and cortical thickness (Gallinat et al., 2006; Nakama et al., 2011; Frank et al., 2013; Grodin et al., 2013; Ide et al., 2014) . This consequence may falsely diminish rTMS efficacy. Indeed, the rTMS magnetic field may not be powerful enough to reach the cortical layer.
4.1.2.2. Gender. Apart from specific aspects of addiction and RD in women, which is not the topic of this review, gender differences have yet to be widely studied in the field of rTMS and addiction. Some gender differences have been shown in depressed rats (Yang et al., 2007) and in schizophrenic humans, with a better response to rTMS in females (Huber et al., 2003) . Moreover, hormonal status affects the response of treatment-resistant depression to rTMS in women (Huang et al., 2008) . It may also have an influence on the clinical expression of some addictive conditions, such as bulimic disorders (Lester et al., 2003) , and may therefore introduce a confounding bias for discussion (Claudino et al., 2011) .
Main exclusion criteria
Psychiatric and somatic comorbidities may be confounding factors in assessing rTMS efficacy in addictive conditions. Fortunately, medical conditions are often an exclusion criterion, because they can be absolute or relative contraindications for rTMS (Rossi et al., 2009) . Psychiatric conditions may also interfere. For example, in eating disorders, improving depressive and obsessive-compulsive symptoms as well as bingeing and purging symptoms may highlight a common physiopathological process rather than the specific efficacy of rTMS (Walpoth et al., 2008) .
4.1.3.1. Associated treatments. While some of the studies examined in our review were careful to exclude patients receiving psychotropic treatments, others included such patients on the condition that treatment had been stable for at least two weeks and even stipulated that ¾ of the patients received anti-craving drugs (such as naltrexone, acamprosate, disulfiram, carbamazepine, or fluoxetine) after completion of the rTMS sessions (Mishra et al., 2010) . Prescribing this type of treatment may interfere with the assessment of craving even when the rTMS is carried out some time later.
4.1.3.2. Handedness. Just one study highlighted the importance of this parameter in their results (Van den Eynde et al., 2010a) . Half of the studies do not specify the subjects' handedness, while the other half looked at right-handed subjects only. This choice is seldom justified. Some authors (Mishra et al., 2010) argued that the application of HF rTMS to the right DLPFC has been hypothesised to produce trans-synaptic suppression of the left DLPFC (i.e., the dominant hemisphere in right-handed individuals) (Fox et al., 1997) . However, others found that applying HF rTMS to the left DLPFC in right-handed individuals also reduced craving (Uher et al., 2005; Van den Eynde et al., 2010b; Li et al., 2013a) . These findings suggest that handedness may not be as important a criterion as has been suggested. Moreover, in some cases the dominant hemisphere may be the right one in right-handed individuals. According to some authors, approximately 95-99% of right-handed individuals have left-hemispheric language dominance, as is the case with approximately 70% of left-handed individuals (Corballis, 2014) . In contrast, some authors have suggested that left-handed people are more likely to suffer from mental disorders from childhood (van der Hoorn et al., 2010) and addictive disorders later in life (Sperling et al., 2000) . When applied to the left DLPFC, rTMS produces different effects in right-handed and left-handed subjects (Van den Eynde et al., 2010a) . Including left-handed individuals in further studies involves taking these last two facts, clinical and ethical issues, into account. Indeed, left-handed people should be included in this research, especially because they may be more likely to suffer from mental disorders (van der Hoorn et al., 2010).
Cortical excitability
rTMS aims to modulate cortical excitability. Its effectiveness greatly depends on the state of neuronal activation in the targeted brain region at the time of stimulation (Silvanto and Pascual-Leone, 2008) . Cortical excitability is determined by a number of factors (Feil and Zangen, 2010) , which, alone or in combination, help change the level of neuronal activity, thereby changing the resulting effects of rTMS. It is precisely for this reason that age, gender, menstrual cycle, level of anxiety or mood, sleep deprivation, substance abuse, thickness of skull layers or brain atrophy, and psychotropic treatments must be accounted for before the start of a study (Rossi et al., 2009 ). Moreover, ethnicity should be taken into consideration (Yi et al., 2014) .
Design
Most of the studies carried out to date assessed the efficacy of rTMS in reducing craving as assessed by Visual Analogue Scales (for more detail, see Table 1 ). While this tool provides a fast measurement of craving that can easily be repeated, the measurement is subjective and fluctuates over time, as well as being subject to the influence of other variables. Less often, the main objective was to investigate the effect of rTMS on substance use or eating behaviour. In these cases, the outcome measures were the number of cigarettes smoked or the number of binges and purges. From a therapeutic point of view, the latter type of studies is more relevant, while the first type may be useful as an exploratory study.
The procedures for inducing craving also varied, sometimes being controlled by exposure to neutral cues, especially in studies relating to nicotine dependence. Participants may have been exposed to cues before and after the rTMS session or during stimulation.
Moreover, attrition bias has also been observed in trials including several rTMS sessions. One of the most ambitious studies had a design closest to the protocol used to test rTMS efficacy in major depression and included measurement of the long-term effect (Amiaz et al., 2009) . It also had the largest number of subjects. However, its results were limited by a high drop-out rate and notably by the authors' decision to run statistical analyses per protocol, which can lead to false positive results.
Technical issues 4.2.1. General considerations
First, rTMS protocols vary immensely. Sometimes the protocol was not specified or the description was rather vague, whereas the parameters used can have a direct impact on rTMS efficacy and the results of the study. This may partly explain the occasionally contradictory results that emerge from these studies. It is therefore difficult to compare the protocols from different trials, which authors often fail to justify or discuss, especially in older studies. Second, the more recent the study was, the more accurate the description of the protocol. This means that broad comparisons have to be drawn. Similarly, the same team tends to use the same protocol, which makes more accurate comparison of the results possible.
The rTMS device
The equipment used may influence the results depending on its ease of handling and intrinsic characteristics. The coil design is also significant and may interfere with the efficacy of rTMS. The depth of penetration and focality on the clinical target are the two main technical features of the coil. Up to now, figure-8 type coils have exhibited the best depth-focality trade-off, compared with circular coils (Deng et al., 2013) . Because most of the studies used this very widespread coil, we think this technical point enhanced the efficacy of rTMS and is not likely to explain the differences between studies. Interestingly, researchers also recently tested the efficacy of deep TMS in behavioural addictions (Rosenberg et al., 2013) , which has not yet been proven.
Stimulation site and identification of target site
In almost all cases, the brain area stimulated was the left DLPFC. Stimulation of the DLPFC can induce the release of dopamine in the caudate nucleus (Strafella et al., 2001) . Thus, repeated stimulation may induce neuroadaptation in the dopaminergic system (Strafella et al., 2003) . Other target regions such as the right DLPFC or DMPFC are also starting to be tested (Downar and Daskalakis, 2013) . The right DLPFC was rarely chosen; however, testing this target may be warranted as it is involved in decision making (Knoch et al., 2006) . We hypothesise that the left DLPFC was more often tested than the right DLPFC or others targets because researchers built their first studies on studies of rTMS and depression. The choice of target region, however, is only of relative significance when one considers that rTMS also produces remote effects (Fox et al., 1997; Mishra et al., 2010) . rTMS not only produces local effects facing the coil but also on the ipsi-and contralateral (inter-hemispheric) cortical side, either inhibiting (Ferbert et al., 1992; Fox et al., 1997) or facilitating cortical activity (Fox et al., 1997; Hanajima et al., 2001) . Stimulating a target region may also modulate the excitability of another one rather than directly stimulating the latter (Rizzo et al., 2004) . These findings are also supported by neuroimaging evidence (Bestmann et al., 2005) . Moreover, the remote effects of rTMS on frontal cortical regions have been noticed in deeper cerebral structures, especially in the mesostriatal system, increasing the release of dopamine (Keck et al., 2002) , and subcortical regions (Hanlon et al., 2013) . For example, stimulation of the DLPFC potentially increases dopamine excretion in the ventral striatum (Strafella et al., 2001 ). In the same way, SFG is also connected to subcortical structures such as the amygdala and striatum (Croxson et al., 2005) . Therefore, stimulating the DLPFC or SFG may ultimately both have remote effects on dopamine release, depending of course on the frequency of stimulation. Because dopamine is particularly involved in the physiopathological processes of addictions and RD, any modulation of its neurotransmission activity is probably more important than the initial target where the stimulation takes place.
Nevertheless, the link with the decision making process must be kept in mind (Bechara, 2005; Redish et al., 2008) . The prefrontal cortex is involved in many aspects of cognitive processes including decision-making to achieve goal directed behaviours. Moreover, its activity depends on motivation to seek treatment (Wilson et al., 2004) and inter-temporal drug availability (McBride et al., 2006; Hayashi et al., 2013) , both related to the issue of self-control.
The methods for identifying the target site have varying levels of precision. The most commonly used, the "5-cm method", has been criticised because it does not take into account interindividual skull size and anatomical variations in the prefrontal cortex (Herbsman et al., 2009; Johnson et al., 2013) . Neuronavigation proved to be a superior target location method for DLPFC compared with the "5-cm method" and the "10-20 method" or the international EEG system (Rusjan et al., 2010; Bradfield et al., 2012; Kim et al., 2013) . Thus, neuronavigational coil positioning seems to increase the therapeutic effects of rTMS in several diseases such as depression Schonfeldt-Lecuona et al., 2010; Nauczyciel et al., 2011) , auditory hallucinations (Klirova et al., 2013) and pain (Ahdab et al., 2010) . However, the research has yet to show evidence for the greater efficacy of rTMS in addictions or RD using neuronavigation, compared with other coil-positioning methods.
4.2.4. General design of the sessions and rTMS parameters 4.2.4.1. Number of sessions. The number of rTMS sessions received by the participants ranged from 1 to 15, and was influenced by the aim of the study and the chosen outcome measures. Changes in behaviour and long-lasting effects were more often seen in patients undergoing repeated rTMS sessions. Similar evidence is seen in the treatment of major depression (Lam et al., 2008) . If participants underwent several sessions, the interval between the two sessions varied from one hour to one week. Little is known about the cumulative and persistent effects of rTMS over time in the treatment of addictions and RD. These particular effects are usually identified by parallel group trials; however, they may result in misinterpretation if a crossover design is used, particularly when the interval is short Johann et al., 2003) or even very short (Li et al., 2013b) .
4.2.4.2. Frequency. HF was used in all of the studies, except two (Rose et al., 2011; Li et al., 2013b) . As previously mentioned, HF stimulation is considered to have excitatory effects on both left and right cortical activity. Regarding the frequency and target site, most of the studies we reviewed showed that HF applied to the left DLPFC had positive results on craving or dependence, whereas others found negative results on craving. When HF is applied to the right DLPFC, two studies showed a positive effect on craving and only one study found a negative effect. It is unfortunate that this decision (HF or LF) was not always motivated by underlying physiopathological hypotheses. When mentioned, the main hypothesis is that HF rTMS has been shown to alter dopaminergic neurotransmission in subcortical structures . Researchers sometimes tend to replicate parameters used by previous teams, without explaining their own hypothesis. It is only recently that LF protocols have begun to be tested. Li et al. (2013b) chose LF for two reasons, the first being safety because individuals with a history of MA usually exhibit significantly increased cortical excitability and often show increased seizure susceptibility, and the second was listed simply as "exploratory". They assumed that LF rTMS, which is inhibitory, would modulate cravings and perhaps even worsen cravings. Finally, they showed that LF rTMS on the left DLPFC transiently increased cue-induced craving in MA participants. Hence, reducing inhibitory control might be one of the possible mechanisms of the LF rTMS. Stimulating the right DLPFC with HF rTMS may result in trans-synaptic suppression of the left DLPFC (Camprodon et al., 2007; Mishra et al., 2010) . Thus we support the idea that the choice of HF or LF in any trial should be made in consideration of other parameters, especially the target site.
Motor threshold and the intensity of stimulation.
Although a visual determination of MT should preferably be avoided, as it tends to overestimate the minimal intensity required to activate the motor cortex (Lefaucheur et al., 2011) , it was widely used in the studies. While rather troublesome to use, the EMG method is more accurate and, more importantly, can be accurately reproduced. The intensity of stimulation thus determines rTMS efficacy. Even if the stimulation intensity at the motor cortex gives an accurate result, there is no evidence that this is more optimal than that at the prefrontal cortex for therapeutic purposes. However, using visual determination of the MT could artificially increase the patient's real MT, and lead to a higher intensity rTMS than that predicted by the protocol. This could thus result in incorrect interpretations and may interfere with the safety of rTMS. Over 100% intensity is thought to be a predictive rTMS response factor in depression (Gershon et al., 2003) . It seems that this is also the case for addiction and RD.
4.2.4.4. The number of trains, intertrain interval, numbers of pulses, and number and duration of sessions. The number of trains, intertrain intervals and pulses per train should be described more often, in line with safety regulations (Rossi et al., 2009 ). The total number of pulses per session was between 1000 and 2000 in most trials, which seems to be suitable for ensuring effective rTMS. Two recent studies actually used 3000 pulses (Barth et al., 2011; Li et al., 2013a) . In fact, a figure higher than 1000 is thought to be predictive of rTMS efficacy in depression (Gershon et al., 2003) , while the number of sessions is said to determine the efficacy of rTMS in the medium and long term (Gershon et al., 2003; Khedr et al., 2005; Amiaz et al., 2009) . In most of the studies examined here, rTMS was carried out in a single session. The effects thus seemed to be very shortlived, lasting from a few seconds to a few minutes. The duration of the session, which was not always stipulated, is nevertheless also a determining factor in regard to assessing the specific effect of rTMS on craving. The natural progression of craving remains poorly understood. According to some authors, craving may be sustained for 30 min following exposure to cues, with a gradual decrease in intensity (Heishman et al., 2010) . It may be hypothesised that under certain conditions (for example, during an excessively long session), craving intensity may actually diminish naturally over the course of a few minutes, and it may instead have been incorrectly attributed to a specific effect of the rTMS. While this risk does exist, it has largely been mitigated through the design of studies with control groups.
Sham procedure
The quality of the placebo method is a crucial issue. The reliability of the results is substantially undermined when authors fail to describe the placebo method used or to optimise it. Using a sham coil alone does not create optimum placebo conditions (Loo et al., 2000) because, among other reasons, it does not produce a tactile sensation on the face or scalp. Fortunately, the placebo method has been gradually improved over time. First, some research teams used electrical stimulation through the skin on the subjects' forehead, over the prefrontal cortex, triggered by the rTMS machine to correspond to sham rTMS pulses (Li et al., 2013a) . Second, the electrical current was titrated to a level matching participants' ratings of real rTMS (Barth et al., 2011; Li et al., 2013a) . Third, some researchers also tested the validity of the sham system at the end of the study by asking participants to guess which rTMS session was real and which was sham (Barth et al., 2011) .
The Hawthorne effect is probably at work when subjects can distinguish between the placebo and the active method. Expressions of craving are eminently subjective, and its intensity may be overestimated or underestimated if the placebo method has not been optimised (Brunoni et al., 2009 ). This was the case for most of the studies, especially where the sham method consisted of simply applying the active coil to the target area at an angle of 45 • -90 • . In this situation, there is probably still slight activity, possibly modulating cortical excitability. There are still too few studies examining the reliability of the placebo method through a patient survey (Broadbent et al., 2011) . Furthermore, the rTMS placebo effect may be linked to the disorder being studied and the study design rather than the treatment itself (Brunoni et al., 2009) . A strong placebo effect is often reported in therapeutic trials carried out in the field of addiction and RD (Hodgins et al., 2011) . Moreover, it has been shown that in crossover studies, a placebo session prior to the active session artificially increases the effect of the latter .
Although blinding efficacy is seldom reported, it is nevertheless a critical component in determining the magnitude of placebo effects in controlled rTMS studies. Assessing the efficacy of blinding should be very helpful for further studies.
Safety and tolerance
Apart from conventional safety recommendations and respecting the exclusion criteria for rTMS, specific points related to addictions must be noted (Rossi et al., 2009) . First, patients exposed to drugs of abuse often show increased seizure susceptibility, and second withdrawal from alcohol or benzodiazepines increases the risk of developing a seizure threshold (Kawasaki et al., 2012; Leach et al., 2012; Ghezzi et al., 2014) . Safety, more than tolerance, which is often good, needs to be balanced with the parameters, especially the frequency, number of pulses, intensity, and number of sessions, required to provide rTMS efficacy.
Future directions
Overall, the use of rTMS in patients with addictions and RD does seem to be a promising treatment that merits further research. Nevertheless, this critical review leads us to propose key recommendations (Table 4) . Neuromodulation may increase cognitive control in various ways, opening up new treatment prospects to help addicted patients by reducing their craving levels (Jansen et al., 2013) . Both the efficacy of this method and real indications for its use has yet to be confirmed. Research should therefore continue by replicating the trials, with particular attention given to their design. Controlled, randomised, double-blind studies, based on larger sample groups should be standard practice. Some authors recommend carrying out international multicentre studies as a way of overcoming recruitment difficulties (Van den Eynde and Guillaume, 2012) .
In addition, the choice of main assessment criteria is crucial. Assessing craving using a VAS is extremely subjective and fluctuates over time under the influence of many factors. A better understanding of the natural fluctuations in cravings is key to reducing factors of confusion. Moreover, the measurement of craving intensity could be coupled with approximate but objective and physiological measurements of craving (Claudino et al., 2011) . Measurement of indirect criteria might also be added to this, such as evaluations of a change in behaviour (for example, a reduction in the number of cigarettes smoked or in the number of binges), provided that the effect of rTMS is evaluated in the medium term, as was done in some of the described studies (Walpoth et al., 2008; Amiaz et al., 2009) and as is recommended by some researchers (Wing et al., 2012) .
As previously mentioned, the beneficial effect observed in most of the studies is only a short-term effect, limiting the intervention's usefulness. Some authors have conducted studies with the design used in the treatment of major depression, with repeated daily sessions of rTMS over a period of several weeks. This design should provide a long-lasting effect. Several authors argue that studies should be developed according to this model based on the hypothesis that repeated, frequent sessions will result in changes in cerebral neuroplasticity and generate a long-lasting effect (Van den Eynde and Guillaume, 2012) . Moreover, the use of multiple rTMS sessions per day may also be a promising therapeutic development, as shown very recently in depression (Baeken et al., 2013) . The efficacy of rTMS should be greatly enhanced when the number of pulses is high (Gershon et al., 2003) . In patients with addictions and RD, several rTMS sessions per day may alleviate efficacy by increasing the number of pulses. We also hypothesise that it may reduce craving, a key symptom in addiction, which may occur several times a day. Safety concerns related to giving several rTMS sessions a day should also be assessed.
Handedness should be considered as one of the inclusion/exclusion criteria and subject handedness should be carefully researched using an appropriate questionnaire. Including lefthanded individuals may improve our understanding of brain functioning (Willems et al., 2014) .
Developing better knowledge of brain mapping in patients with addiction may help determine which brain regions other than the DLPFC could be tested. This may not be as important as it appears because of the remote effects of rTMS, which have been discussed above. Finally, the hemispheric differences of the DLPFC in addiction should also be a matter of debate. These unresolved issues should be clarified in future studies. They are all the more important because hemispheric differences in human beings are still being discussed (Corballis, 2014) . For this reason, both left-and rightsided rTMS could be compared in the same trial to clarify the role of the two sides in regulating craving. In the future, identification of the target area may rely on methods other than the "5-cm" method, as evidenced by the superior efficacy of neuronavigation in the treatment of depression. This statement must be taken very carefully because to date, no evidence of the superiority of neuronavigation has yet been found for rTMS in patients with addictions and RD. LF rTMS on both the right and left DLPFC should be tested to specify more precisely whether it might influence craving or not. Inhibition by LF in regions in which hyperactivity is discovered during craving induction, especially the right DLPFC could be interesting. LF is all the more interesting for safety reasons, with a lower risk of seizure compared with HF.
The intensity of treatment and the number of pulses per session could be increased and still remain in line with safety regulations (Rossi et al., 2009 ). Optimising and standardising stimulation parameters does present a challenge but is a necessary step that many authors have called for (Barr et al., 2008; Feil and Zangen, 2010; Diana, 2011; Wing et al., 2012) . Detailed descriptions of the protocols used in the articles would enhance the repeatability of these trials and thus facilitate comparisons of the results of different studies. This would be a first step towards meta-analyses that would be useful for interpreting results as suggested by some authors (Van den Eynde and Guillaume, 2012) .
Moreover, clinical and non-clinical predictors of treatment outcomes must be determined to provide more detailed indications of neuromodulation. To our knowledge, only one study reached the conclusion that rTMS had a more intense effect on heavy smokers than light smokers (Li et al., 2013a ) (for a description of the parameters, see Table 2 ). In other areas, work on outcome predictors identified exogenic and endogenic factors. Variability in cortical excitability may also be linked to genetic characteristics, in the same way that responses to medications can be influenced by genetic variability (Sturgess et al., 2011) . In contrast, the modulation of several genes may be involved in the therapeutic mechanisms of rTMS (Ikeda et al., 2013) .
Finally, physiological measurements, such as electroencephalography, PET-scan or fMRI, should be associated with clinical studies to enhance our knowledge of the underlying mechanisms of both addictions and RD, particularly concerning the dopaminergic brain reward systems and rTMS action (Pripfl et al., 2013b) .
Implementation of these recommendations would allow neuromodulation through rTMS to take its place in the spectrum of therapeutic strategies, alongside other neuromodulation techniques, psychotherapies and pharmacotherapies.
